Garadacimab for hereditary angioedema prophylaxis: long term efficacy and safety from the Phase 3 VANGUARD trial and first interim analysis of the open-label extension trial

A. Reshef,M. Magerl,I. Martinez Saguer,J. A. Bernstein,H. Farkas,W. H. Yang,J. S. Jacobs, P. Hei Li,W. R. Lumry,E. Aygoeren-Puersuen, I. Ohsawa,C. Katelaris,H. Longhurst,R. Hakl,M. Guilarte,E. S. G. Stroes,H. Feuersenger, M. A. Bica,I. Jacobs,T. J. Craig

ALLERGOLOGIE（2023）

引用 0|浏览1

暂无评分

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要